# Phase 2 Heart Failure trials recruiting: 44 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 44 trials in phase 2 for Heart Failure that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Heart Failure trials: 44 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/heart-failure

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 44
- Recruiting or not yet: 44
- Read on: November 19, 2026

## Trials

The 25 newest of 44, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07920887 | A Study of Bimagrumab in Participants With HFpEF | Eli Lilly and Company | Phase 2 | Not yet recruiting | Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction, Heart Failure, Preserved... | 540 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920887) |
| October 5, 2026 | NCT07857772 | This Will be a Randomized Comparison of the Proteomic Effects of Vicadrostat/Empagliflozin Versus Empagliflozin and Versus... | Baim Institute for Clinical Research | Phase 2 | Not yet recruiting | Heart Failure With Preserved Ejection Fraction (HFPEF) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857772) |
| September 4, 2026 | NCT07805811 | Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure | Johns Hopkins University | Phase 2 | Not yet recruiting | Heart Failure, Caregiver | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805811) |
| August 31, 2026 | NCT07795814 | A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF) | Edgewise Therapeutics, Inc. | Phase 2 | Recruiting | Heart Failure With Preserved Ejection Fraction | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795814) |
| August 6, 2026 | NCT07750873 | A Trial of CRD-4730 in HFrEF | Cardurion Pharmaceuticals, Inc. | Phase 2 | Recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 525 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750873) |
| July 9, 2026 | NCT07692256 | the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients | Ain Shams University | Phase 2 | Recruiting | Heart Failure | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692256) |
| May 18, 2026 | NCT07594145 | Precision T1D Platform - New Therapies for Cardio-Renal Complications | Oregon Health and Science University | Phase 2 | Not yet recruiting | Type 1 Diabetes, T1D Heart Failure, Cardio-renal Vascular Function and Failure, Diabetic Chronic Kidney Disease | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594145) |
| May 13, 2026 | NCT07584967 | A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure | AnaCardio AB | Phase 2 | Recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584967) |
| May 8, 2026 | NCT07576257 | OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension) | Sahlgrenska University Hospital | Phase 2 | Not yet recruiting | Heart Failure | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576257) |
| March 27, 2026 | NCT07499037 | Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO | University Hospital Ostrava | Phase 2 | Not yet recruiting | Pneumonia, Heart Failure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07499037) |
| March 10, 2026 | NCT07461961 | CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock | Brigham and Women's Hospital | Phase 2 | Not yet recruiting | Cardiogenic Shock, Heart Failure, Inflammation | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07461961) |
| March 2, 2026 | NCT07443696 | PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy | Sinotau Pharmaceutical Group | Phase 2 | Recruiting | Ischemic Cardiomyopathy, Heart Failure | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07443696) |
| February 6, 2026 | NCT07394270 | Effect of Add-on L-Arginine Therapy on Heart Failure Patients | German University in Cairo | Phase 2 | Not yet recruiting | Heart Failure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07394270) |
| December 26, 2025 | NCT07304817 | Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) | University Medical Center Groningen | Phase 2 | Recruiting | CKD, Cardiovascular Diseases, Heart Failure | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07304817) |
| December 10, 2025 | NCT07273838 | Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome | Yale University | Phase 2 | Recruiting | Heart Failure, Acute Kidney Injury | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07273838) |
| November 24, 2025 | NCT07245069 | Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients | University Medical Centre Ljubljana | Phase 2 | Recruiting | Heart Failure, Anthracycline-induced Cardiac Toxicity, Endothelial Function (FMD), Arterial Stiffness, Breast Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07245069) |
| June 19, 2025 | NCT07029503 | Swedish Cardiac And Renal Failure Study-1 | Karolinska Institutet | Phase 2 | Recruiting | HFrEF - Heart Failure With Reduced Ejection Fraction, Chronic Kidney Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07029503) |
| May 27, 2025 | NCT06991257 | A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) | Pfizer | Phase 2 | Recruiting | Heart Failure | 620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06991257) |
| May 19, 2025 | NCT06979375 | A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly... | Novo Nordisk A/S | Phase 2 | Recruiting | Heart Failure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06979375) |
| May 19, 2025 | NCT06979362 | A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure... | Novo Nordisk A/S | Phase 2 | Recruiting | Heart Failure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06979362) |
| May 11, 2025 | NCT06965621 | 18F-mFBG Imaging for Myocardial Sympathetic Innervation | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | Phase 2 | Recruiting | Heart Failure, Ischemic Cardiomyopathy, ICD Patients | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06965621) |
| February 28, 2025 | NCT06851949 | Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure | Sponsor not shown (see the record) | Phase 2 | Recruiting | Heart Failure With Reduced Ejection Fraction | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06851949) |
| January 27, 2025 | NCT06793371 | AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF | Cytokinetics | Phase 2 | Recruiting | Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06793371) |
| November 26, 2024 | NCT06705023 | Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with... | Sponsor not shown (see the record) | Phase 2 | Recruiting | Myocardial Injury, LV Dysfunction, Coronary Artery Disease, Heart Failure | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06705023) |
| November 1, 2024 | NCT06669169 | Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure | Tasly Pharmaceutical Group Co., Ltd | Phase 2 | Not yet recruiting | Heart Failure | 288 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06669169) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Alberta | 2 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 2 |
| Yale University | 2 |
| University Medical Centre Ljubljana | 2 |
| Population Health Research Institute | 1 |
| Karolinska Institutet | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| Baylor Research Institute | 1 |
| Sahlgrenska University Hospital | 1 |
| National Heart Centre Singapore | 1 |
| University of Leeds | 1 |
| Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 1 |
| Ain Shams University | 1 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| University Medical Center Groningen | 1 |
| Johns Hopkins University | 1 |
| Hospices Civils de Lyon | 1 |
| University Hospital, Akershus | 1 |
| [Tasly Pharmaceutical Group Co., Ltd](https://specstream.ai/data/clinical-trials/company/tasly-pharmaceutical-group-co-ltd) | 1 |
| Stanford University | 1 |
| German University in Cairo | 1 |
| University of Washington | 1 |
| Washington University School of Medicine | 1 |
| Mayo Clinic | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 20 |
| Canada | 7 |
| Poland | 5 |
| United Kingdom | 5 |
| Czechia | 4 |
| Spain | 4 |
| Sweden | 3 |
| China | 3 |
| Japan | 3 |
| Brazil | 2 |
| Bulgaria | 2 |
| France | 2 |
| Hungary | 2 |
| Egypt | 2 |
| Netherlands | 2 |
| Germany | 2 |
| India | 2 |
| South Korea | 2 |
| Slovenia | 2 |
| Russia | 1 |
| Argentina | 1 |
| Puerto Rico | 1 |
| Israel | 1 |
| Singapore | 1 |
| Italy | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Web design firms in the United States](https://specstream.ai/data/businesses/web-design-firms/united-states)
- [Corporate gift suppliers in the United States](https://specstream.ai/data/businesses/corporate-gift-suppliers/united-states)
- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [Resorts in the United States](https://specstream.ai/data/businesses/resorts/united-states)
- [Avionics shops in the United States](https://specstream.ai/data/businesses/avionics-shops/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
